Emcure Pharmaceuticals Ltd. – Strategic SWOT Analysis Review

Date: 2015-10

“Emcure Pharmaceuticals Ltd. – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – GlobalData’s summarization of the company’s business strategy.
– SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.


Emcure Pharmaceuticals Ltd. (Emcure) is a fast growing Indian pharmaceutical company. It develops, manufactures and markets a wide range of pharmaceutical products worldwide. The company specializes in the development and manufacture of differentiated pharmaceutical products. Emcure also manufactures active pharmaceutical ingredients (APIs) primarily for use in manufacturing of pharmaceutical products. Emcure has presence in all major therapeutic areas including cardiology, pain and analgesics, HIV, gynecology, blood related, anti-infective, nephrology, diabetes, oncology, and vitamins, minerals and nutrients products. It operates subsidiaries in Brazil, Dubai, South Africa, Singapore and Nigeria. The company has branch offices in Russia and Morocco. Emcure is headquartered in Pune, Maharashtra, India.

Emcure Pharmaceuticals Ltd. Key Recent Developments

Jul 14, 2015: FDA Bans Imports From Emcure Pharmaceuticals’ Manufacturing Unit In India
Feb 25, 2015: Heritage Pharmaceuticals Initiates a Nationwide Voluntary Recall of Colistimethate for Injection USP, 150 mg and Rifampin for Injection USP, 600 mg/vial Due to a Lack of Sterility Assurance
Mar 01, 2013: Roche Likely To Cut Down Prices Of Two Cancer Drugs In India

Reasons to Buy

– Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
– Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
– Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
– Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.”

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample